Herbalife (NYSE:HLF) Reaches New 1-Year Low – Time to Sell?

Shares of Herbalife Ltd. (NYSE:HLF) hit a new 52-week low during mid-day trading on Friday . The company traded as low as $6.43 and last traded at $6.46, with a volume of 4312974 shares trading hands. The stock had previously closed at $7.10.

Wall Street Analysts Forecast Growth

HLF has been the subject of several analyst reports. B. Riley lowered their price objective on Herbalife from $17.00 to $12.00 and set a “buy” rating for the company in a research note on Thursday, October 31st. StockNews.com raised shares of Herbalife from a “hold” rating to a “buy” rating in a research note on Monday, November 4th. Mizuho raised their target price on shares of Herbalife from $8.00 to $9.00 and gave the stock a “neutral” rating in a report on Friday, November 1st. Citigroup cut their price target on shares of Herbalife from $16.00 to $13.00 and set a “buy” rating on the stock in a report on Friday, October 25th. Finally, DA Davidson reduced their price objective on shares of Herbalife from $13.00 to $7.50 and set a “neutral” rating on the stock in a research report on Thursday, October 31st. One analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, Herbalife currently has a consensus rating of “Hold” and an average target price of $9.90.

Herbalife Price Performance

The stock has a market cap of $653.13 million, a PE ratio of 7.62, a price-to-earnings-growth ratio of 0.27 and a beta of 1.17. The business has a fifty day moving average of $7.63 and a 200-day moving average of $8.77.

Herbalife (NYSE:HLF) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.57 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.19 by $0.38. The business had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.23 billion. Herbalife had a negative return on equity of 18.66% and a net margin of 1.73%. As a group, equities research analysts predict that Herbalife Ltd. will post 1.51 EPS for the current year.

Hedge Funds Weigh In On Herbalife

Hedge funds and other institutional investors have recently modified their holdings of the business. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its stake in Herbalife by 72.1% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 168,209 shares of the company’s stock valued at $1,209,000 after purchasing an additional 70,498 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of Herbalife by 6.9% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 2,479,957 shares of the company’s stock worth $17,831,000 after buying an additional 160,792 shares during the last quarter. Baupost Group LLC MA grew its position in shares of Herbalife by 128.3% in the 2nd quarter. Baupost Group LLC MA now owns 5,124,526 shares of the company’s stock worth $53,244,000 after buying an additional 2,879,603 shares during the last quarter. Marshall Wace LLP raised its stake in shares of Herbalife by 2,053.6% during the 2nd quarter. Marshall Wace LLP now owns 1,977,155 shares of the company’s stock worth $20,543,000 after acquiring an additional 1,885,346 shares in the last quarter. Finally, Maverick Capital Ltd. lifted its position in Herbalife by 409.4% during the second quarter. Maverick Capital Ltd. now owns 127,887 shares of the company’s stock valued at $1,329,000 after acquiring an additional 102,784 shares during the last quarter.

About Herbalife

Herbalife Ltd. provides health and wellness products in North America, Mexico, South and Central America, Europe, the Middle East, Africa, China, and the Asia Pacific. It offers products in the areas of weight management; targeted nutrition; energy, sports, and fitness; outer nutrition; and literature and promotional items.